版本:
中国

BRIEF-Shire and Parion Sciences enter into a collaborative license agreement

May 1 Shire Plc:

* Shire and Parion Sciences enter into a collaborative license agreement to advance p-321 for ophthalmic indications

* Demonstrates ongoing commitment to innovation in ophthalmics for Shire

* Shire Plc will make initial $20 million upfront license payment with an additional $20 million payment based on milestone

* Parion will be entitled to receive additional potential milestone payments, with a total potential deal value of up to $535 million

* Parion has option to co-fund through additional stages of development in exchange for enhanced tiered double-digit royalties.

* Parion also has option to co-fund commercialization activities and participate in financial outcome from those activities. Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐